|
BROOKLYN, NY USA -- HEALTHCARE UPDATE NEWS SERVICE™ -- APRIL 4, 2019: Announcing the release of the 4th Edition of Rx Data News, a publication dedicated to exploring the impact of data science, analytics, machine learning and artificial intelligence on the biopharmaceutical Industry.
SPECIAL SAVINGS: Visit our subscription page today and enter to following PROMO CODES:
- RXDATA20 - 20% Off an Individual Subscription ($250 value)
- RXDATA30 - 30% Off a Group Subscription - 10 Licenses ($1500 value)
- RXDATA40 - 40% Off an Enterprise Subscription - up to 50 Licenses ($3800 value)
|
FEATURED CONTENT IN ISSUE IV:
|
- Exclusive Interview: Dr. James Cai, Head of Data Science, Roche Translational Clinical Research Center
- Data Integrity: Regulators and Pharma Industry Seek New Solutions to Data Manipulation and Falsification
- Monthly Deep Focus: What Impact has Data Science and the Technologies Associated with it had on Pharmaceutical Research & Development?
- Deep Focus Response: Dr. Mats Sundgren, Director, Health Informatics, AstraZeneca
- Industry Reports and Surveys Emphasize Importance of Data Standardization, Quality and Access
- Deep Focus Response: Dr. Dan Riskin, Founder and CEO, Verantos
- Accenture, Merk and Amazon Web Services (AWS) Collaborate on Cloud-Based Informatics Research Platform: In-Depth Interview
- Monthly Rx Data News-in-Brief
|
|
|
|
GUEST CONTRIBUTORS:
|
Dr. James Cai
Head of Data Science, Roche Translational Clinical Research Center, New York, NY |
Dr. Mats Sundgren
Director, Health Informatics, AstraZeneca, Stockholm, Sweden |
Dr. Dan Riskin
Founder and CEO, Verantos, Palo Alto, CA
|
Joe Donahue
Managing Director, Life Sciences R&D, Accenture, Philadelphia, PA |
Hal Stern
Executive Director of Applied Technology, Merck & Company, New York, NY
|
|
Visit www.RxDataNews.com to download a free sample issue and SUBSCRIBE today. Every issue contains originally reported articles, exclusive interviews and thought leader commentary.
|
